|
| Press Releases |
|
 |
|
| Wednesday, September 8, 2021 |
|
|
阿诺医药宣布AN2025、AN0025与atezolizumab三联治疗晚期实体瘤1a期临床在美国完成首例患者给药 |
阿诺医药，一家专注于肿瘤治疗领域的创新型全球生物制药公司，今日宣布其口服泛PI3K抑制剂buparlisib（AN2025）、口服EP4拮抗剂（AN0025）与PD-L1抑制剂atezolizumab（阿替利珠单抗）三联疗法在晚期/转移性实体瘤患者中开展的Ia期临床试验已于美国成功完成首例患者给药。
more info >> |
|
|
阿諾醫藥宣佈AN2025、AN0025與atezolizumab三聯治療晚期實體瘤1a期臨床在美國完成首例患者給藥 |
| 阿諾醫藥，一家專注於腫瘤治療領域的創新型全球生物製藥公司，今日宣佈其口服泛PI3K抑制劑buparlisib（AN2025）、口服EP4拮抗劑（AN0025）與PD-L1抑制劑atezolizumab（阿替利珠單抗）三聯療法在晚期/轉移性實體瘤患者中開展的Ia期臨床試驗已于美國成功完成首例患者給藥。 more info >> |
|
|
Adlai Nortye Announces First Patient Dosed in Phase Ia Clinical Trial of AN2025 and AN0025 in Combination with atezolizumab for Advanced Solid Tumors |
| Adlai Nortye, a global biopharmaceutical company focused on developing innovative oncology drugs, today announced that the first patient has been dosed in the Phase Ia clinical trial in the U.S. to evaluate the triple combination of AN2025 (buparlisib, oral pan-PI3K inhibitor), AN0025 (oral EP4 antagonist) and atezolizumab (PD-L1 inhibitor) in patients with locally advanced/metastatic tumors. more info >> |
|
| Thursday, July 15, 2021 |
|
|
Adlai Nortye Raises $100 Million in Series D Financing, Co-led by SDIC Fund Management and Tigermed, participated by Legend Star, WuXi Biologics Healthcare Ventures |
| Adlai Nortye Ltd. (hereinafter referred to as "Adlai Nortye"), a global biopharmaceutical company focused on developing innovative oncology drugs, today announced the completion of $100 million Series D financing round. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
On Its Centennial: The Occasion of Replacing the Kiswa of the Noble Kaaba Embodies the Kingdom of Saudi Arabia's Enduring Care for the Two Holy Mosques
Jun 26, 2025 23:46 HKT/SGT
|
|
|
IBI Announces 23-Fold Surge in Net Profit for FY2025
Jun 26, 2025 22:37 HKT/SGT
|
|
|
IBI公佈2025財年淨利潤大幅增長23倍 在充滿挑戰的環境中實現強勁業績
Jun 26, 2025 22:24 HKT/SGT
|
|
|
IBI公布2025财年净利润大幅增长23倍 在充满挑战的环境中实现强劲业绩
Jun 26, 2025 22:08 HKT/SGT
|
|
|
Wasion Wins Three Major Smart Power Meter Contracts In Emerging Overseas Markets, Total Contract Value Exceeds HK$940 million
Jun 26, 2025 20:58 HKT/SGT
|
|
|
威勝控股集團成功於海外新興市場奪得三項大型智能電表合約 總價值逾9.4億港元
Jun 26, 2025 20:46 HKT/SGT
|
|
|
威胜控股集团成功于海外新兴市场夺得三项大型智能电表合约 总价值逾9.4亿港元
Jun 26, 2025 20:33 HKT/SGT
|
|
|
AEON Credit Reported Rebound Growth in 1QFY2025/26, Net Profit Up 31.3% to HK$109.3 million
Jun 26, 2025 20:01 HKT/SGT
|
|
|
AEON信貸財務於二零二五/二六財年第一季度錄得反彈增長 純利增31.3%至1.093億港元
Jun 26, 2025 19:54 HKT/SGT
|
|
|
AEON信贷财务于二零二五/二六财年第一季度录得反弹增长 纯利增31.3%至1.093亿港元
Jun 26, 2025 19:41 HKT/SGT
|
|
|
Regina Miracle FY25 Net Profit Up by 28.4% to HK$180 Million
Jun 26, 2025 19:19 HKT/SGT
|
|
|
維珍妮25財年純利增28.4%至1.8億港元 末期息每股4.3港仙
Jun 26, 2025 19:05 HKT/SGT
|
|
|
维珍妮25财年纯利增28.4%至1.8亿港元 末期息每股4.3港仙
Jun 26, 2025 18:36 HKT/SGT
|
|
|
World's Premier AI Conference, World AI Show - Indonesia 2025, Arrives in Jakarta to Power Southeast Asia's AI Revolution
Jun 26, 2025 12:31 HKT/SGT
|
|
|
Honda Opens "Honda Software Studio Osaka" as New Software Development Operation
Jun 26, 2025 13:30 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
